AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers LagsInvestors Business Daily • 04/25/24
Bristol Myers Squibb reports narrower-than-expected first-quarter loss, sales top estimatesMarket Watch • 04/25/24
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, FasterBusiness Wire • 04/22/24
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to DeclineZacks Investment Research • 04/18/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMYPRNewsWire • 04/12/24
Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)Seeking Alpha • 04/12/24
Wall Street Favorites: 3 Warren Buffett Stocks With Strong Buy Ratings for April 2024InvestorPlace • 04/12/24
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 NamesInvestorPlace • 04/11/24